NCT07886099

Brief Summary

This study aims to investigate the acute effects of a circuit breathing intervention on nicotine withdrawal symptoms and respiratory parameters among youth who use e-cigarettes.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
1mo left

Started Aug 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress90%
Aug 2026Oct 2026

Study Start

First participant enrolled

August 15, 2026

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 10, 2026

Completed
5 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 21, 2026

Completed
9 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2026

Expected
Last Updated

October 21, 2026

Status Verified

October 1, 2026

Enrollment Period

2 months

First QC Date

October 10, 2026

Last Update Submit

October 16, 2026

Conditions

Keywords

Circuit breathingNicotine withdrawal symptomsE CigaretteFractional exhaled nitric oxideRespiratory Function

Outcome Measures

Primary Outcomes (2)

  • E-cigarette Dependence

    E-cigarette dependence will be assessed using the Penn State Electronic Cigarette Dependence Index, adapted by Sornsenee et al. (2025). The questionnaire consists of 10 items, with a maximum total score of 20. Scores are interpreted as follows: 0-3 indicates no e-cigarette dependence, 4-8 indicates low dependence, 9-12 indicates moderate dependence, and 13 or higher indicates high dependence.

    Baseline for demographic data.

  • Nicotine Withdrawal Symptoms

    Nicotine withdrawal symptoms will be assessed using the Thai version of the Minnesota Nicotine Withdrawal Scale-Revised (MNWS) (Hughes \& Hatsukami, 2008), translated by Sirirat Kanokururot and Sunida Preechawong (2010). This self-report questionnaire measures the perceived severity of nicotine withdrawal symptoms. It consists of 9 items rated on a 5-point scale ranging from 0 (no symptoms) to 4 (severe symptoms). The total score ranges from 0 to 36, with a score of 0 indicating no nicotine withdrawal symptoms and a score of 36 indicating the most severe nicotine withdrawal symptoms.

    Immediately before and immediately after each breathing intervention session.

Secondary Outcomes (2)

  • Fractional Exhaled Nitric Oxide (FeNO)

    Immediately before and immediately after each breathing intervention session.

  • Peak Nasal Inspiratory Flow (PNIF)

    Immediately before and immediately after each breathing intervention session.

Study Arms (3)

Circuit Breathing

EXPERIMENTAL
Other: Circuit breathing

Diaphragmatic Breathing

EXPERIMENTAL
Other: Diaphragmatic Breathing

Normal Breathing

EXPERIMENTAL
Other: Normal Breathing Condition

Interventions

The circuit breathing intervention consists of five stations: paper suction using a straw, blowing a toy pinwheel, incentive spirometry, balloon blowing, and weighted diaphragmatic breathing. Participants will rest for 1 minute between stations.

Circuit Breathing

The diaphragmatic breathing exercise will consist of inhaling through the nose for 4 seconds and exhaling through the nose for 6 seconds, continuously for 10 minutes per set. Participants will rest for 1 minute between sets and complete a total of 3 sets.

Diaphragmatic Breathing

Participants will breathe normally through the nose without deliberately controlling the rate, rhythm, or depth of breathing. Breathing will remain at each participant's natural pace for approximately 30 minutes.

Normal Breathing

Eligibility Criteria

Age15 Years - 25 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Male or female aged 15-25 years.
  • Regular e-cigarette use for at least six months and current e-cigarette use, defined as use on at least one day per week or at least 10 puffs per day during the past 30 days.
  • Not regularly physically active, defined as exercising fewer than two times per week during the preceding six months.
  • Able to understand instructions, communicate effectively, and cooperate with the research procedures.
  • No history of cardiovascular disease or respiratory disease, such as asthma or chronic obstructive pulmonary disease.
  • No uncontrolled hypertension. Participants with controlled hypertension must have resting blood pressure ≤140/90 mmHg.
  • Able to move independently without assistance or assistive devices.
  • Willing to participate and provide informed consent.
  • For participants younger than 18 years, consent from a parent or legally authorized representative is required.

You may not qualify if:

  • Development of an illness, injury, or other circumstance that prevents continued participation.
  • Withdrawal of consent or unwillingness to continue participation.
  • Current use of illicit drugs or other tobacco/nicotine products, including conventional cigarettes, shisha/hookah, roll-your-own tobacco, or other nicotine-containing products.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Sports Science, Chulalongkorn University

Bangkok, Bangkok, 10330, Thailand

RECRUITING

MeSH Terms

Conditions

VapingRespiratory Aspiration

Condition Hierarchy (Ancestors)

SmokingBehaviorRespiration DisordersRespiratory Tract DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Wannaporn Tongtako, Ph.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

October 10, 2026

First Posted

October 21, 2026

Study Start

August 15, 2026

Primary Completion

October 15, 2026

Study Completion (Estimated)

October 30, 2026

Last Updated

October 21, 2026

Record last verified: 2026-10

Data Sharing

IPD Sharing
Will not share

Locations